Subjects with above-median YAP or mTOR pathway activation displayed worse overall and disease-free survival (Fig. 7c–f), suggesting that beyond tumor initiation, YAP and mTOR pathway activation may contribute to tumor progression and influence prognostic outcomes. The gene discussed is YAP1; the disease is neoplasm.